Psychiatry & Neurology Doctors in Madison, MS Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Dr. Varun Sreenivasan, MD Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Accepting Medicare Assignments Practice Location: 7730 Old Canton Rd Bldg A, Madison, MS 39110 Phone: 601-499-0935    Fax: 601-984-5503

Dr. Elizabeth Henderson Perry, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 118 Depot Dr, Madison, MS 39110 Phone: 601-605-9599    Fax: 601-605-1950

Sara Porter, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 401 Baptist Dr Ste 301, Madison, MS 39110 Phone: 601-499-0935    Fax: 601-499-0936

News Archive

Roche, ATCC partner to research real-time endogenous GPCR function with xCELLigence System

G-coupled protein receptors (GPCRs), also known as 7-transmembrane proteins, constitute the single largest class of therapeutic targets for clinical and investigational drugs. There are ~800 predicted members of this class in the human genome, involved in diverse signaling pathways in a wide array of cells and tissue types. Modulation of GPCR function has proven to have therapeutic benefit in a wide variety of diseases in immunology, neurology, cardiology, and oncology.

Biologists demonstrate highly effective method for delivering HIV-fighting antibodies

In 2011, biologists at the California Institute of Technology (Caltech) demonstrated a highly effective method for delivering HIV-fighting antibodies to mice-a treatment that protected the mice from infection by a laboratory strain of HIV delivered intravenously.

Mice sleeping fitfully help unravel mystery of insomnia

Mice that sleep fitfully could help researchers unravel the mystery of insomnia. Researchers at Washington University School of Medicine in St. Louis studied mice genetically modified to mimic the genetic disease neurofibromatosis type 1, which is associated with sleep problems.

Positive results from Genomic Health's Oncotype DX study in breast cancer patients with node-positive disease

Genomic Health, Inc. today announced that The Lancet Oncology published positive results from a study of Oncotype DX(®) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute-supported clinical trials cooperative group.

Read more Medical News

› Verified 2 days ago